Cargando…

Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections

Pseudomonas aeruginosa is one of the most common causes of healthcare-associated diseases and is among the top three priority pathogens listed by the World Health Organization (WHO). This Gram-negative pathogen is especially difficult to eradicate because it displays high intrinsic and acquired resi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holger, Dana, Kebriaei, Razieh, Morrisette, Taylor, Lev, Katherine, Alexander, Jose, Rybak, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151982/ https://www.ncbi.nlm.nih.gov/pubmed/34064648 http://dx.doi.org/10.3390/antibiotics10050556

Ejemplares similares

132. Evaluation Phage Cocktails in Combination with Ciprofloxacin Against Multidrug-Resistant Pseudomonas aeruginosa Overexpressing MexAB-OprM Efflux Systems
por: Holger, Dana, et al.
Publicado: (2021)

1295. Activity of SPR206, a Polymyxin B Derivative, Compared to Colistin Alone and in Combination Against Multidrug-Resistant Pseudomonas aeruginosa Strains
por: Abdul-Mutakabbir, Jacinda C, et al.
Publicado: (2020)

Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections In Vitro: Bacteriophage-Antibiotic Combination
por: Kebriaei, Razieh, et al.
Publicado: (2022)

Evaluation of Bacteriophage-Antibiotic Combination Therapy for Biofilm-Embedded MDR Enterococcus faecium
por: Lev, Katherine, et al.
Publicado: (2022)

1573. Daptomycin Resistant Enterococcus faecium: Combination Therapy Screening
por: Kebriaei, Razieh, et al.
Publicado: (2020)

Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
por: Kunz Coyne, Ashlan J., et al.
Publicado: (2022)

1297. In-Vitro Antibacterial Activities of Cefiderocol (S-649266) Alone and With the Addition of Beta-Lactamase Inhibitors Against Multidrug-resistant Acinetobacter baumannii
por: Abdul-Mutakabbir, Jacinda C, et al.
Publicado: (2020)

Impact of Ceftolozane–Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections
por: Holger, Dana J., et al.
Publicado: (2022)

Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant Enterococcus faecium with Preserved Phage Susceptibility
por: Coyne, Ashlan J. Kunz, et al.
Publicado: (2022)

Preclinical Development of a Bacteriophage Cocktail for Treating Multidrug Resistant Pseudomonas aeruginosa Infections
por: Camens, Sophie, et al.
Publicado: (2021)

Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant Enterococcus faecium and faecalis
por: Barber, Katie E., et al.
Publicado: (2021)

Identification and Characterization of New Bacteriophages to Control Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Endotracheal Tubes
por: Oliveira, Viviane C., et al.
Publicado: (2020)

The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA—Salvaging the Gold Standards with Combination Therapy
por: Morrisette, Taylor, et al.
Publicado: (2020)

Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa
por: Köhler, Thilo, et al.
Publicado: (2023)

The prevalence of Pseudomonas aeruginosa and multidrug resistant Pseudomonas aeruginosa in healthy captive ophidian
por: Sala, Andrea, et al.
Publicado: (2019)

Effect of methylglyoxal on multidrug-resistant Pseudomonas aeruginosa
por: Hayashi, Katsuhiko, et al.
Publicado: (2014)

Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals
por: Telling, Kaidi, et al.
Publicado: (2018)

The Selection of Antibiotic- and Bacteriophage-Resistant Pseudomonas aeruginosa Is Prevented by Their Combination
por: Ferran, Aude A., et al.
Publicado: (2022)

2254. Multicenter Evaluation of Ceftazidime–Avibactam for Multidrug-Resistant Pseudomonas aeruginosa Infections
por: Jorgensen, Sarah C J, et al.
Publicado: (2019)

Author Correction: Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa
por: Köhler, Thilo, et al.
Publicado: (2023)

Emergence and Spread of Epidemic Multidrug-Resistant Pseudomonas aeruginosa
por: Miyoshi-Akiyama, Tohru, et al.
Publicado: (2017)

Complete Genome Sequence of the Myoviral Bacteriophage YS35, Which Causes the Lysis of a Multidrug-Resistant Pseudomonas aeruginosa Strain
por: Yu, Sheng, et al.
Publicado: (2018)

Successful Bacteriophage-Antibiotic Combination Therapy against Multidrug-Resistant Pseudomonas aeruginosa Left Ventricular Assist Device Driveline Infection
por: Racenis, Karlis, et al.
Publicado: (2023)

Pharmacokinetic/Pharmacodynamic (PK/PD) Evaluation of Dalbavancin Alone and in Combination with Ceftaroline against Methicillin-Resistant Strains (MRSA) of Staphylococcus aureus
por: Kebriaei, Razieh, et al.
Publicado: (2017)

Carbapenem Susceptibility and Multidrug-Resistance in Pseudomonas aeruginosa Isolates in Egypt
por: Hashem, Hany, et al.
Publicado: (2016)

S33.1 Multidrug-resistant Acinetobacter baumanii and Pseudomonas aeruginosa
Publicado: (2005)

Exposure of Pseudomonas aeruginosa to Cinnamaldehyde Selects Multidrug Resistant Mutants
por: Tetard, Alexandre, et al.
Publicado: (2022)

Development of a Bacteriophage Cocktail to Constrain the Emergence of Phage-Resistant Pseudomonas aeruginosa
por: Yang, Yuhui, et al.
Publicado: (2020)

Pseudomonas aeruginosa Resistance to Bacteriophages and Its Prevention by Strategic Therapeutic Cocktail Formulation
por: Vaitekenas, Andrew, et al.
Publicado: (2021)

Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection
por: Ferry, T., et al.
Publicado: (2022)

Bacteriophage Infectivity Against Pseudomonas aeruginosa in Saline Conditions
por: Scarascia, Giantommaso, et al.
Publicado: (2018)

Bacteriophage–Antibiotic Combination Therapy against Pseudomonas aeruginosa
por: Santamaría-Corral, Guillermo, et al.
Publicado: (2023)

A Small Multidrug Resistance Transporter in Pseudomonas aeruginosa Confers Substrate-Specific Resistance or Susceptibility
por: Wegrzynowicz, Andrea K., et al.
Publicado: (2023)

Virulence Characteristics and an Action Mode of Antibiotic Resistance in Multidrug-Resistant Pseudomonas aeruginosa
por: Hwang, Wontae, et al.
Publicado: (2019)

Antimicrobial resistance of Pseudomonas aeruginosa in a Romanian hospital at the dawn of multidrug resistance
por: Gavriliu, Liana-Catalina, et al.
Publicado: (2016)

Assessing Rates of Co-Resistance and Patient Outcomes in Multidrug-Resistant Pseudomonas aeruginosa
por: Appaneal, Haley J., et al.
Publicado: (2022)

Evaluation of Rapid Polymyxin Pseudomonas test in clinical Pseudomonas aeruginosa isolates with various degrees of multidrug resistance
por: Sánchez-López, Javier, et al.
Publicado: (2021)

Polimixin B use in treatment of multidrug-resistant Pseudomonas aeruginosa infection
por: Gouveia, LS, et al.
Publicado: (2003)

Multidrug Resistant Pseudomonas aeruginosa in Iran: A Systematic Review and Metaanalysis
por: Vaez, Hamid, et al.
Publicado: (2018)

Gene regulatory network inference and analysis of multidrug-resistant Pseudomonas aeruginosa
por: Medeiros, Fernando, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4p1bd01nl1urit9vc2mh78jgf5